Intravitreal triamcinolone acetonide: potential complications

被引：1

作者：

Vasconcelos-Santos, Daniel Vitor ^{[1
,2
]}

Nehemy, Marcio B. ^{[3
]}

Rich, Ryan McKay ^{[4
]}

Negrao, Silvana ^{[4
]}

Flynn, Harry W., Jr. ^{[5
]}

机构：

[1] HC Univ Fed Minas Gerais, Hosp Sao Geraldo, Uveitis Unit, BR-30130100 Belo Horizonte, MG, Brazil

[2] HC Univ Fed Minas Gerais, Hosp Sao Geraldo, Retina & Vitreous Unit, BR-30130100 Belo Horizonte, MG, Brazil

[3] HC Univ Fed Minas Gerais, Hosp Sao Geraldo, Ophthalmol, BR-30150270 Belo Horizonte, MG, Brazil

[4] Univ Miami, Miller Sch Med, Dept Ophthalmol, Bascom Palmer Eye Inst, Miami, FL 33136 USA

[5] Univ Miami, Miller Sch Med, Dept Ophthalmol, Bascom Palmer Eye Inst,Ophthalmol, Miami, FL 33136 USA

来源：

EXPERT REVIEW OF OPHTHALMOLOGY | 2007年 / 2卷 / 06期

关键词：

adverse effects; corticosteroids; intravitreal injections; risk factors; triamcinolone acetonide; vitreous body;

D O I：

10.1586/17469899.2.6.987

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Intravitreal injection of triamcinolone acetonide (IVTA) has been used as an off-label strategy in the management of a wide range of edematous, neovascular and inflammatory retinal diseases. Despite the variable success rates achieved in each disease, a variety of adverse events have been reported. These may be associated with the intravitreal injection procedure (endophthalmitis, vitreous hemorrhage and retinal detachment), preservatives in the vehicle of the drug (intraocular toxicity and noninfectious endophthalmitis) and the corticosteroid itself (cataract, ocular hypertension and infection). This article aims to review the incidence and mechanisms of the potential adverse effects of IVTA injection.

引用

页码：987 / 999

页数：13

共 159 条

[1] Conjunctival ulceration following triamcinolone injection [J].

Agrawal, S ;

Agrawal, J ;

Agrawal, TP .

AMERICAN JOURNAL OF OPHTHALMOLOGY, 2003, 136 (03) :539-540

[2] Vitrectomy as a treatment for elevated intraocular pressure following intravitreal injection of triamcinolone acetonide [J].

Agrawal, S ;

Agrawal, J ;

Agrawal, TP .

AMERICAN JOURNAL OF OPHTHALMOLOGY, 2004, 138 (04) :679-680

[3] Evolving guidelines for intravitreous injections [J].

Aiello, LP ;

Brucker, AJ ;

Chang, S ;

Cunningham, ET ;

D'Amico, DJ ;

Flynn, HW ;

Grillone, LR ;

Hutcherson, S ;

Liebmann, JM ;

O'Brien, TP ;

Scott, IU ;

Spaide, RF ;

Ta, C .

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2004, 24 (05) :S3-S19

[4] Long-term retinal toxicity of intravitreal commercially available preserved triamcinolone acetonide (Kenalog) in rabbit eyes [J].

Albini, Thomas A. ;

Abd-El-Barr, Muhammad M. ;

Carvounis, Petros E. ;

Iyer, Mohan N. ;

Lakhanpal, Rohit R. ;

Pennesi, Mark E. ;

Chevez-Barrios, Patricia ;

Wu, Samuel M. ;

Holz, Eric R. .

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2007, 48 (01) :390-395

[5] Intravitreal triamcinolone for the treatment of idiopathic juxtafoveal telangiectasis [J].

Alldredge, CD ;

Garretson, BR .

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2003, 23 (01) :113-116

[6] Intravitreal triamcinolone for uveitic cystoid macular edema: An optical coherence tomography study [J].

Antcliff, RJ ;

Spalton, DJ ;

Stanford, MR ;

Graham, EM ;

Ffytche, TJ ;

Marshall, J .

OPHTHALMOLOGY, 2001, 108 (04) :765-772

[7]

ARMALY MANSOUR F., 1965, INVEST OPHTHALMOL, V4, P187

[8] EFFECT OF CORTICOSTEROIDS ON INTRAOCULAR PRESSURE AND FLUID DYNAMICS .1. EFFECT OF DEXAMETHASONE IN NORMAL EYE [J].

ARMALY, MF .

ARCHIVES OF OPHTHALMOLOGY, 1963, 70 (04) :482-+

[9] Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration [J].

Augustin, AJ ;

Schmidt-Erfurth, U .

OPHTHALMOLOGY, 2006, 113 (01) :14-22

[10] Intravitreal triamcinolone injection for chronic diffuse diabetic macular oedema [J].

Avci, R ;

Kaderli, B ;

Akalp, FD .

CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2006, 34 (01) :27-32

← 1 2 3 4 5 6 7 8 9 10 →